Use the Back button in your browser to see the other results of your search or to select another record.
| 2012 Brazilian Society of Rheumatology consensus for the treatment of rheumatoid arthritis |
| da Mota LM, Cruz BA, Brenol CV, Pereira IA, Rezende-Fronza LS, Bertolo MB, de Freitas MV, da Silva NA, Louzada-Junior P, Giorgi RD, Lima RA, da Rocha Castelar Pinheiro G [Brazilian Society of Rheumatology] |
| Revista Brasileira de Reumatologia [Brazilian Journal of Rheumatology] 2012 Mar-Apr;52(2):152-174 |
| practice guideline |
|
OBJECTIVE: to elaborate recommendations for the treatment of rheumatoid arthritis in Brazil. METHOD: literature review with articles' selection based on evidence and the expert opinion of the Rheumatoid Arthritis Committee of the Brazilian Society of Rheumatology. RESULTS AND CONCLUSIONS: (1) The therapeutic decision should be shared with the patient; (2) immediately after the diagnosis, a disease-modifying antirheumatic drug (DMARD) should be prescribed, and the treatment adjusted to achieve remission; (3) treatment should be conducted by a rheumatologist; (4) the initial treatment includes synthetic DMARDs; (5) methotrexate is the drug of choice; (6) patients who fail to respond after two schedules of synthetic DMARDs should be assessed for the use of biologic DMARDs; (7) exceptionally, biologic DMARDs can be considered earlier; (8) anti-TNF agents are preferentially recommended as the initial biologic therapy; (9) after therapeutic failure of a first biologic DMARD, other biologics can be used; (10) cyclophosphamide and azathioprine can be used in severe extra-articular manifestations; (11) oral corticoid is recommended at low doses and for short periods of time; (12) non-steroidal anti-inflammatory drugs should always be prescribed in association with a DMARD; (13) clinical assessments should be performed on a monthly basis at the beginning of treatment; (14) physical therapy, rehabilitation, and occupational therapy are indicated; (15) surgical treatment is recommended to correct sequelae; (16) alternative therapy does not replace traditional therapy; (17) family planning is recommended; (18) the active search and management of comorbidities are recommended; (19) the patient's vaccination status should be recorded and updated; (20) endemic-epidemic transmissible diseases should be investigated and treated.
Additional document(s) available for this guideline: |